MedPath

Effectiveness of TAP Block Versus Intravenous Analgesia in Postoperative Pain Management Following Gynecologic Laparoscopic Surgery

Active, not recruiting
Conditions
Postoperative Pain
Interventions
Drug: TAP Block Group
Registration Number
NCT07051499
Lead Sponsor
University of Foggia
Brief Summary

Optimal postoperative pain control is crucial in laparoscopic gynecologic surgery, particularly within Enhanced Recovery After Surgery (ERAS) protocols. The transversus abdominis plane (TAP) block is a regional anesthesia technique that may reduce opioid consumption and enhance recovery. However, data comparing TAP block directly with standard intravenous analgesia in this surgical context are limited.

Detailed Description

This prospective, randomized controlled trial included patients undergoing laparoscopic gynecologic procedures (e.g., myomectomy, ovarian cystectomy, endometriosis surgery). Patients were randomized into two groups:

* TAP Block Group: Bilateral ultrasound-guided TAP block with 0.25% levobupivacaine and 75 mcg clonidine per side, plus standard intraoperative intravenous analgesia (ketorolac, tramadol, ondansetron).

* Intravenous Analgesia Group: Standard intraoperative intravenous analgesia as above, followed by a postoperative elastomeric pump delivering tramadol 500 mg and ondansetron in 100 ml saline at 2 ml/h for 48 hours.

Primary outcome: Postoperative pain intensity (NRS) at 1, 6, and 24 hours. Secondary outcomes included additional analgesic use, side effects, and patient satisfaction.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • age > 18 years, scheduled for elective gynecological surgery
Exclusion Criteria
  • age <18, emergency surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
intravenous analgesiaTAP Block GroupStandard intraoperative intravenous analgesia as above, followed by a postoperative elastomeric pump delivering tramadol 500 mg and ondansetron in 100 ml saline at 2 ml/h for 48 hours.
Primary Outcome Measures
NameTimeMethod
Postoperative pain intensity (Numeric Rating Scale)1, 6, 24 hours postoperatively.

Postoperative pain will be assessed using the 11-point Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain. Pain scores will be recorded at 1, 6, and 24 hours postoperatively.

Secondary Outcome Measures
NameTimeMethod
Total Analgesic Consuption.0-24 hours postoperatively.

Total dose of tramadol (in Milligrams) administered in the first 24 hours after surgery will be recorded and compared between groups.

Incidence of Side Effects.0-24 hours postoperatively

Occurrence of side effects such nausea, vomiting and sedation will be recorded and expressed as a percentage of patients (%) affected in each group.

Patient Satisfaction With Analgesia24 hours postoperatively

Patient satisfaction with postoperative pain management will be assessed using a 5-point Likert scale (1= very dissatisfied; 5= very satisfied) at 24 hours after surgery.

Trial Locations

Locations (1)

Policlinico di Foggia

🇮🇹

Foggia, Puglia, Italy

Policlinico di Foggia
🇮🇹Foggia, Puglia, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.